Get access to our best features
Get Started
SubscribeLogin
Get access to our best features
Get Started
Published

Baltimore company designing rheumatoid arthritis drug gets OK from FDA to start testing on patients

Summary by Ground News
About 1.5 million Americans suffer from rheumatoid arthritis, a chronic disease. Drugs such as Humira and Enbrel block a molecule called tumor necrosis factor alpha. MyMD-1 can be taken as a tablet, rather than injection or infusion, and its molecules are small.
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Annapolis

Annapolis

Trending Topics
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2025 Snapwise Inc
News
For You
Search
BlindspotLocal